University of California
Pre-Clinical Research: Engineering CD34+ Hematopoietic Stem Cells
University of California, San Francisco, California, United States, 94199
Home
>
Pre-Clinical Research: Engineering CD34+ Hematopoietic Stem CellsPre-Clinical Research: Engineering CD34+ Hematopoietic Stem Cells
Location: 3739 Balboa Street #1057, San Francisco, CA 94121, United StatesJob Posted Date: July 23, 2024Positions Available: Part-time, Postdoc, VolunteerPopulation: Life SciencesOur organization received funding and is conducting pre-clinical research in transplant medicine, focusing on genetic engineering techniques to improve organ transplant compatibility and reduce rejection. The intention of the pre-clinical trial is to get the results published in a scientific journal and evaluate implementation in transplant recipients.We are specifically studying two potential pathways:Deactivation of HLA genes in donor organs using CRISPR-Cas9 delivered via lentiviral vectors or electroporation.Creating chimeric bone marrow via engineered CD34+ cells.Job Requirements:Experience/Skills:Gene knockout engineering using lentiviral vectors or electroporation and CRISPR-Cas9Strong knowledge of the immune systemGood Laboratory Practice (GLP) standards with animal modelsResearch design and scientific investigation backgroundPreferred Experience:Understanding of hematopoietic stem cell chimerismFamiliarity with FDA approval processesPost-doctorate or PhDHow to Apply:Send email with resume to Austin@Cardioclone.com
#J-18808-Ljbffr
>
Pre-Clinical Research: Engineering CD34+ Hematopoietic Stem CellsPre-Clinical Research: Engineering CD34+ Hematopoietic Stem Cells
Location: 3739 Balboa Street #1057, San Francisco, CA 94121, United StatesJob Posted Date: July 23, 2024Positions Available: Part-time, Postdoc, VolunteerPopulation: Life SciencesOur organization received funding and is conducting pre-clinical research in transplant medicine, focusing on genetic engineering techniques to improve organ transplant compatibility and reduce rejection. The intention of the pre-clinical trial is to get the results published in a scientific journal and evaluate implementation in transplant recipients.We are specifically studying two potential pathways:Deactivation of HLA genes in donor organs using CRISPR-Cas9 delivered via lentiviral vectors or electroporation.Creating chimeric bone marrow via engineered CD34+ cells.Job Requirements:Experience/Skills:Gene knockout engineering using lentiviral vectors or electroporation and CRISPR-Cas9Strong knowledge of the immune systemGood Laboratory Practice (GLP) standards with animal modelsResearch design and scientific investigation backgroundPreferred Experience:Understanding of hematopoietic stem cell chimerismFamiliarity with FDA approval processesPost-doctorate or PhDHow to Apply:Send email with resume to Austin@Cardioclone.com
#J-18808-Ljbffr